The patent application review is currently paused to gather more data for patentability. A decision is expected in 2025. Immunovia is ready to adapt to US political changes, like increased FDA oversight on lab tests, ensuring success regardless.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing